Treatment of arteriovenous malformations (AVMs) is complicated because of many factors including increasing size, eloquent location, and risk of unacceptable neurological deficits. Each of the treatment modalities, microsurgery, embolization, and stereotactic radiosurgery (SRS), has its pros and cons. Surgery and embolization are limited by location, size, and afferent and efferent vessel anatomy. Stereotactic radiosurgery is limited by size and location, with increasing volume of the AVM resulting in decreasing the therapeutic dose. Many articles address the concern of high dose radiation not being able to be used in SRS over a large volume. [1] [2] [3] [4] [5] Embolization is an endovascular treatment that often precedes surgical excision or stereotactic radiosurgery for the treatment of AVMs. [6] [7] [8] This type of combination is typically utilized for larger AVMs (>3 cm 3 ) in order to reduce the overall size needed to be treated through microsurgical removal or SRS. 6, 7, 9, 10 Staged gamma knife radiosurgery (GKRS) provides another method of treating larger AVMs and is based on the idea of safe re-treatment; however, unlike re-treatment which occurs approximately three years after the first treatment, staged SRS is multiple treatments over shorter period of time (~3 to 8 months).
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We present a case showing successful obliteration of a large AVM in a 12-year-old male through the use of embolization to initially reduce nidus size followed by staged gamma knife radiosurgery. To the author's knowledge successful obliteration of a large AVM by combining staged embolization with stagedvolume GKRS has not previously been described.
CASE MATERIAL

Patient History
A 12-year-old male presented with complaints of dizziness and severe headaches. The patient did not describe any other complaints. The physical exam and family history were unremarkable. A CT scan was ordered and revealed a large (22.6 cc) and complex left posterior parietal cortical AVM. Further investigations included MRI and conventional 4-vessel angiography.
Treatment Plan
Microsurgery was deemed inappropriate because of the AVM size. In addition, the volume of the AVM prevented the use of a single gamma knife treatment. A plan was organized that consisted of using staged-embolization to reduce the AVM nidus volume followed by staged-GKRS treatments to complete obliteration. As is important for any staged-GKRS treatment, MRI was used to plan the staged radiosurgical treatments. A flow 
BRIEF COMMUNICATIONS
chart of the overall treatment plan is shown in Figure 1 . EMBOLIZATION In order to reduce the volume of the AVM prior to GKRS the patient had three successful embolization procedures using Onyx as the embolization material. Catherization was performed with a transfemoral approach using standard coaxial techniques. The three embolization treatments were performed over a six-month 
Obliteration
Confirmed by Angiogram
period with each treatment separated by two-months. Three pedicles were taken in the first embolization procedure while only two were taken in the second and third procedures. Following the third embolization it was felt that the size of the AVM (now 18.4cc) was adequately reduced to allow for 2-staged GKRS treatments to complete the treatment of the AVM.
Staged Gamma Knife Treatment
Following the last embolization procedure a 2-stage GKRS treatment plan was recommended. Stage-1 of GKRS was performed two-months after the last embolization treatment. Eighteen Gy was delivered to a 6.5cc region of the total 18.4cc AVM. Figure 2 shows the angiography that was acquired immediately prior to the stage-1 procedure.
The second stage of GKRS was performed 6-months after stage-1. The AVM nidus had reduced to 6.3cc following the first GKRS treatment. The residual AVM was treated with 19 Gy delivered over a 4.8cc region. Figure 3 shows the angiography that was acquired immediately prior to stage-2 of GKRS.
Patient Outcome
Obliteration of the initial 22.6cc AVM was confirmed by angiography three-years after the second stage of the GKRS sequence (shown in Figure 4 ). The patient suffered no adverse effects from either the radiation treatments or the embolization procedures, and has fully recovered. The patient suffered no complications as of four-years since the last radiosurgical treatment. The combination of embolization and staged GKRS allowed for obliteration to be achieved in this large AVM in a pediatric patient when other methods were deemed high risk.
DISCUSSION
Several treatment options exist for AVMs including surgical excision, embolization, stereotactic radiosurgery, or a combination of approaches. The ultimate goal of any treatment option is complete obliteration or removal of the AVM eliminating the risk of hemorrhage. The type of treatment modality chosen is primarily based on AVM size and location. None of the treatment options are without risks it is thus necessary to weigh the risk to the patient if the AVM is not treated against the treatment risk. The natural history of AVMs proves useful in helping with this decision.
Several studies have looked at the natural history of AVMs primarily focused on the annual risk of rupture. [15] [16] [17] [18] The majority of AVMs carry a 2-5% risk of hemorrhage per year with a significant lifetime risk of death if bleeding does occur. [15] [16] [17] [18] The risk of rupture is cumulative with 20-50% of patients having hemorrhagic events ten years after initial presentation. Risk of hemorrhage is not eliminated until the AVM is completely obliterated. Decisions to treat must be done on the basis of the long-term cumulative rupture risk.
Surgical excision has been shown to be useful in removing AVMs of small volume located in less eloquent areas typically with Spetzler-Martin grades I-III. 19 If complete excision of the AVM is obtained the risk of hemorrhage to the patient is virtually eliminated post-surgery. The limits of surgical excision occur when the AVM is located in an eloquent location and/or of large volume usually a Spetzler-Martin grade of IV and V. 19 Radiosurgical treatment of AVMs reduces the AVM volume over a period of several years until obliteration is achieved around three to five years post-radiosurgery. The patient thus remains at risk for bleeding for a period following treatment. Treatment using radiosurgery is based on eliminating the longterm risk of AVM rupture.
Embolization of AVMs eliminates blood flow through the AVM, reducing the nidus volume. Small AVMs have been shown to be successfully treated using embolization alone. Surgical excision of AVMs can be complicated when high vascular flow occurs through the AVM. Spetzler et al reported the use of staged embolization to reduce flow allowing for previously inoperable lesions to be removed through surgical excision. 10 Larger AVMs theoretically could be reduced in volume through the use of embolization prior to radiosurgery; however, studies have shown a reduction in obliteration rate when embolization precedes unstaged GKRS. 6, 7, 9, 20, 21 Although a reduction in obliteration rate is observed for large AVMS (10-20cc) this method may still be useful in treating very large AVMs (>20cc). The reduction in obliteration rate when embolization precedes unstaged GKRS for large AVMs opened the way for staged GKRS as another method of achieving obliteration in very large AVMs.
The numbers of patients in the few studies on staged stereotactic radiosurgery in the medical literature are limited; however, they are encouraging as an option for patients with AVMs that could not be successfully treated by any other method. 18, 22, 23 Staged-volume GKRS allows for smaller portions of the AVM to receive higher doses of radiation over a series of treatments usually separated by six-month intervals as was done in this patient. Higher doses of radiation have been shown to correspond with higher rates of obliteration. The time period between treatments is currently done rather arbitrarily. Studies looking at the interval between treatments would be very valuable although to date it has not been a focus of the literature. This method has been shown to result in good obliteration rates with limited complications. 23 A concern in treating patients with staged GRKS is that they remain susceptible to hemorrhage through each stage. An additional concern is that after partially treating the AVM the risk of hemorrhage is increased. 23 Embolization prior to staged-GKRS may provide a method of both reducing AVM volume to be treated as well as reducing the risk of hemorrhage between staged treatments.
The successful use of embolization with a single radiosurgery treatment, although reported at a reduced obliteration rate has previously been described. 6, 7, 9, 10, 20 The use of staged embolization followed by staged-volume GKRS has not previously been reported in the literature. Using embolization prior to staged GKRS allows for a reduction in nidus volume prior to radiosurgery and may reduce the risk of complications between each stage of radiosurgery. This also allows for higher doses of radiation to be given to the patient, which would increase the patient's chances to achieve AVM obliteration. 1, 21, [24] [25] [26] [27] [28] [29] By combining embolization and staged GKRS it is possible that the patient will need fewer stages of GKRS and have a decreased risk of complications between the treatment stages.
One of the more interesting observations seen in this case is that each stage of the gamma knife treatment reduced the AVM size more than the treated volume. The first stage treated 6.5cc of the 18.4cc AVM resulting in a reduction of the AVM volume by 12.1cc. The second stage treated 4.8cc of the 6.3cc AVM and was sufficient to achieve complete obliteration of the AVM. Both stages obtained greater AVM volume reduction than the volume treated. This suggests that it may be possible to achieve sufficient reduction in AVM volume by treating a volume that is smaller than the AVM. Focusing on treating the central region of the AVM may allow the periphery of the AVM to be obliterated in conjunction with the central region and allows for higher doses of radiation to be used safely. This treatment possibility would be best tested using a randomized-control trial and should be looked at as a possible way to improve the effectiveness of radiosurgery treatment for AVM's. Focusing on treating the center of the nidus through each stage also has a lower risk of adverse radiation effects compared to fractionation in which different parts of the nidus are treated at each stage. This is likely a result of higher exposure of normal tissue to radiation when fractionation staging is performed.
It is important to treat a patient with an AVM as soon as possible in order to prevent the patient from increased risk of bleeding that occurs with time. This study suggests a potential treatment combination using staged embolization followed by staged GKRS for the successful treatment of large AVMs in patients when other treatment options may not be reasonable. Although embolization prior to staged radiosurgery has been described in the literature, to the author's knowledge combining staged embolization with staged-volume radiosurgery has not previously been described in the literature.
